Investor Contact

Media & Investor Relations:
Troy Wichterman 
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc. 
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.

Press Releases

BioLife Solutions Announces Earnings Call Date and Upcoming Investor and Scientific Conferences
Q4 & FY2019 Earnings Conference Call on March 11th at 4:30 PM EST

 

BOTHELL, Wash., Feb, 12, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced the dates for several key events:

Cell and gene therapy tools. (PRNewsfoto/BioLife Solutions, Inc.)

Q4 & FY2019 Earnings Conference Call

The Company's fourth quarter and full year 2019 financial results will be released after market close on Wednesday, March 11, 2020 and the Company will host a conference call and live webcast at 4:30 p.m. ET (1:30 p.m. PT) that afternoon. Management will provide an overview of the Company's financial results and a general business update. 

To access the webcast, log on to the Investor Relations page of the BioLife Solutions website at www.biolifesolutions.com/earnings. Alternatively, you may access the live conference call by dialing (844) 825-0512 (U.S. & Canada) or (315) 625-6880 (International) with the following Conference ID:  9098230. A webcast replay will be available approximately two hours after the call and will be archived on www.biolifesolutions.com for 90 days.

Investor Conferences

  • Cowen 40th Annual Healthcare Conference; March 2-4, 2020: Boston Marriott Copley Place
  • 2020 Stephens West Coast 1x1 Conference; March 12, 2020: The Palace Hotel, San Francisco
  • Oppenheimer 30th Annual Healthcare Conference; March 17-18, 2020: InterContinental New York Barclay
  • B. Riley FBR's 21st Annual Institutional Investor Conference; May 20-21, 2020: Beverly Hilton

Scientific Conferences

  • CAR TCR Summit Europe; February 24-27, 2020: Hotel Novotel London West
  • Innate Killer Summit 2020 | Hanson Wade; March 24-26, 2020: Westin San Diego
  • Advanced Therapies Congress & Expo; March 30April 1, 2020: Business Design Centre, London
  • Massachusetts Association of Blood Banks (MABB); April 7-8, 2020: Mansfield, MA
  • American Association of Cancer Research (AACR) Annual Meeting; April 24-29, 2020: San Diego Convention Center
  • American Society of Gene & Cell Therapy (ASGCT) Annual Meeting; May 12-15, 2020; Hynes Convention Center, Boston
  • Allogeneic Cell Therapies Summit 2020 | Hanson Wade; May 19-21, 2020; Sheraton Boston Hotel
  • ISCT Annual Meeting; May 27-30, 2020: Palais des congres de Paris, France

About BioLife Solutions

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction tools. Our tools portfolio includes our proprietary CryoStor® freeze media, HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, and Custom Biogenic Systems high capacity storage freezers. For more information, please visit www.biolifesolutions.com, and follow BioLife on Twitter  

Media & Investor Relations
Roderick de Greef
Chief Financial Officer
(425) 686-6002
rdegreef@biolifesolutions.com

 

SOURCE BioLife Solutions, Inc.